BBVASM 5Y SNP USD: Fair Value T+100 vs IPT T+125 — 25bp Cushion
Summary: BBVA launched a USD benchmark 5-year senior non-preferred today at IPT of T+125 area (Baa1/A-/A-, May 2031 maturity, $200k denoms, 7-bank syndicate). Triangulating across the Santander 4.867% Apr 2031 secondary, BBVA's own USD SNP curve interpolation, and the EUR-USD cross-currency basis adjustment, fair value lands around T+100, implying an IPT new issue concession of approximately 25bp.
Deal terms
Item Detail Issuer Banco Bilbao Vizcaya Argentaria SA Format SEC-reg, Senior Non-Preferred Tenor 5Y (May 8, 2031) Ratings Baa1 / A- / A- IPT T+125 area Denoms 200k x 200k Settlement May 8, 2026
Fair value triangulation
Anchor 1 — Santander 4.867 Apr 2031 (closest peer, priced 3 weeks ago):
Metric Value Mid price 99.485 YTM ~4.99% 5Y UST 4.06% Implied T-spread T+93
Anchor 2 — BBVA own USD SNP curve interpolation:
Bond Tenor T-spread BBVASM 4.150 Mar 2029 2.85Y T+~85 BBVASM 5.127 Mar 2036 9.85Y T+157 5Y interpolation 5.0Y T+~105
Anchor 3 — EUR cross-check (xccy basis adjusted):
Input Value BBVASM EUR 5Y SNP secondary MS+~50/55 5Y EUR/USD basis ~+13bp USD-equivalent T-spread T+~106
Fair value summary
Method Implied 5Y FV SAN 5Y peer + BBVA premium T+98–103 BBVA curve interpolation T+~105 EUR cross-check T+~106 Central FV T+100
NIC and likely outcome
Stage Spread NIC vs FV IPT T+125 +25bp Likely guidance revision T+105/110 +5–10bp Expected landing T+95–100 -5 to flat
Expected size: $1.0–1.5bn, single tranche. BBVA's Feb 2026 USD multi-tranche printed $2.5bn on $9.2bn book (3.7x). A clean 5Y bullet should attract similar relative demand, likely 3.5–5x covered.
On-the-break expectation: New issues from this class of issuer typically tighten 3–7bp post-stabilisation when landed with a small concession. Performance will track the SAN 4.867 Apr 2031 line.
This post is for information only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Spread levels and pricing observations are estimates based on publicly available market signals and may not reflect executable levels. Readers should conduct their own analysis and consult a regulated financial adviser before making any investment decision.
